Precision medicine for molecular-targeted drugs using pharmacokinetics and metabolomics
Project/Area Number |
25460185
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Tottori University |
Principal Investigator |
Shimada Miki 鳥取大学, 医学部附属病院, 教授 (10196488)
|
Co-Investigator(Kenkyū-buntansha) |
MANO NARIYASU 東北大学病院, 教授 (50323035)
|
Co-Investigator(Renkei-kenkyūsha) |
MAEKAWA MASAMITSU 東北大学病院, 助教 (70572882)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 分子標的薬 / 副作用発現 / 薬物動態学パラメーター / 治療継続 / メタボロミクス / 薬物動態学的パラメーター / ソラフェニブ / 肝細胞癌患者 / 血清メタボロミクス / 治療効果 / 副作用 / バイオマーカー探索 |
Outline of Final Research Achievements |
To establish the precision medicine for molecular-targeted drugs, we have performed the study on the pharmacokinetics and the pharmacodynamics in this study.Our data obtained the monitoring the blood concentration of drug and its major metabolite in patients suggests that pharmacokinetic parameters of molecular-targeted drugs are predictive markers for therapeutic and adverse effects. Prelinarly, we have performed proteome analysis on the blood of patients prior/after taking molecular-targeted drugs. Between prior/after taking molecular-targeted drugs, we observed the difference of several endogenous compounds related to glycolysis/gluconeogenesis, TCA cycle, or citric acid cycle.
|
Report
(4 results)
Research Products
(59 results)
-
[Journal Article] Outcomes of a Long-term Case Review Program during the On-site Training of Pharmacy Students2015
Author(s)
Yuriko Murai, Hiroyuki Suzuki, Masaru Mori, Hidehisa Tasaka, Naoto Suzuki, Miki Shimada, Hiroshi Sato, Noriyasu Hirasawa, Nariyasu Mano, Yoshihisa Tomioka.
-
Journal Title
YAKUGAKU ZASSHI
Volume: 135
Issue: 7
Pages: 917-923
DOI
NAID
ISSN
0031-6903, 1347-5231
Year and Date
2015-07-01
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Monitoring Serum Levels of Sorafenib and Its <i>N</i>-Oxide Is Essential for Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma2015
Author(s)
Miki Shimada, Hoshimi Okawa, Yasuteru Kondo, Takahiro Maejima, Yuta Kataoka, Kanehiko Hisamichi, Masamitsu Maekawa, Masaki Matsuura, Yuko Jin, Masaru Mori, Hiroyuki Suzuki, Tooru Shimosegawa, Nariyasu Mano.
-
Journal Title
The Tohoku Journal of Experimental Medicine
Volume: 237
Issue: 3
Pages: 173-182
DOI
NAID
ISSN
0040-8727, 1349-3329
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.2015
Author(s)
Komura T, Miura K, Shirasaka T, Ohnuma S, Shimada M, Kajiwara T, Fujishima F, Philchenkov A, Nakagawa K, Kudoh K, Haneda S, Toshima M, Kohyama A, Musha H, Naitoh T, Shibata C, Unno M.
-
Journal Title
Int J Clin Oncol
Volume: 20
Pages: 117-125
Related Report
Peer Reviewed
-
[Journal Article] Functional characterization of twenty-one CYP2C19 allelic variants for clopidogrel 2-oxidation2015
Author(s)
Masamitsu Takahashi, Takahiro Saito, Miyabi Ito, Chiharu Tsukada, Yuki Katono, Hiroki Hosono, Masamitsu Maekawa, Miki Shimada, Nariyasu Mano, Akifumi Oda, Noriyasu Hirasawa, Masahiro Hiratsuka
-
Journal Title
Pharmacogenomics J,
Volume: 15
Pages: 26-32
Related Report
Peer Reviewed
-
[Journal Article] Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann–Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiency.2015
Author(s)
Masamitsu Maekawa, Miki Shimada, Kousaku Ohno, Masami Togawa, Hiroshi Nittono, Takashi Iida, Alan F. Hofmann, Junichi Goto, Hiroaki Yamaguchi, Nariyasu Mano.
-
Journal Title
Ann Clin Biochem,
Volume: in press
Related Report
Peer Reviewed
-
[Journal Article] Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration.2015
Author(s)
Kajiwara T, Miura K, Ohnuma S, Shimada M, Komura T, Toshima M, Kohyama A, Kudoh K, Haneda S, Musha H, Naitoh T, Shirasaka T, Unno M.
-
Journal Title
Int J Clin Oncol.
Volume: in press
Related Report
Peer Reviewed
-
[Journal Article] A quantitative HPLC-UV method for determination of serum sorafenib and sorafenib N-oxide and its application in hepatocarcinoma patients2014
Author(s)
Shimada M, Okawa H, Maejima T, Yanagi T, Hisamichi K, Matsuura M, Akasaka K, Tsuchiya M, Kondo Y, Shimosegawa T, Mori M, Maekawa M, Suzuki H, Mano N.
-
Journal Title
Tohoku J Exp Med.,
Volume: 233
Pages: 103-112
NAID
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Tacrolimus inhibits the revascularization of isolated pancreatic islets2013
Author(s)
Nishimura R, Nishioka S, Fujisawa I, Shiku H, Shimada M, Sekiguchi S, Fujimori K, Ushiyama A, Matsue T, Ohuchi N, Satomi S, Goto M
-
Journal Title
PLOS ONE
Volume: 8(4)
Issue: 4
Pages: 1-8
DOI
Related Report
Peer Reviewed
-
[Journal Article] LC/ESI-MS/MS analysis of urinary 3β-sulfooxy-7β-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: New biomarkers for the detection of Niemann–Pick type C disease2013
Author(s)
Masamitsu Maekawa, Yasushi Misawa, Ayako Sotoura, Hiroaki Yamaguchi, Masami Togawa,Kousaku Ohno, Hiroshi Nittono, Genta Kakiyama, Takashi Iida, Alan F. Hofmann, Junichi Goto, Miki Shimada, Nariyasu Mano
-
Journal Title
Steroids
Volume: 78
Pages: 967-972
Related Report
Peer Reviewed
-
-
-
[Presentation] Safe long-term sorafenib therapy in hepatocellular carcinoma patients requires monitoring of serum levels of sorafenib and its N-oxide: a pilot study2016
Author(s)
Miki Shimada, Hoshimi Okawa, Yasuteru Kondo, Takahiro Maejima, Yuta Kataoka, Kanehiko Hisamichi, Masamitsu Maekawa, Masaki Matsuura, Yuko Jin, Tooru Shimosegawa, and Nariyasu Mano
Organizer
American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2016 Annual Meeting
Place of Presentation
Hilton SanDiego (SanDiego, U.S.A)
Year and Date
2016-03-08
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
[Presentation] Safe, long-term sorafenib treatment of patients with hepatocellular carcinoma is associated with2015
Author(s)
Miki Shimada, Hoshimi Okawa, Yasuteru Kondo, Takahiro Maejima, Yuta Kataoka, Kanehiko Hisamichi, Masamitsu Maekawa, Masaki Matsuura, Yuko Jin, Tooru Shimosegawa and Nariyasu Mano
Organizer
20th North American ISSX Meeting
Place of Presentation
The Hilton Orlando Bonnet Creek (Orlando, U.S.A)
Year and Date
2015-10-18
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-